Non-small cell lung cancer stage I
Information
- Disease name
- Non-small cell lung cancer stage I
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03383302 | Active, not recruiting | Phase 1/Phase 2 | SBRT With Immunotherapy in Early Stage Non-small Cell Lung Cancer: Tolerability and Lung Effects | February 8, 2018 | February 2026 |
| NCT06180239 | Active, not recruiting | Segmentectomy vs Lobectomy | January 1, 2017 | December 31, 2024 | |
| NCT03603002 | Active, not recruiting | N/A | Pathologic and Immunologic Response After Ablative Radiation in Lung Cancer | October 16, 2018 | December 2024 |
| NCT03216551 | Completed | Mediastinal Staging Accuracy of a Selective Lymphadenectomy Strategy in Early Stage NSCLC (ECTOP-1003) | March 14, 2019 | May 30, 2022 | |
| NCT04271384 | Completed | Phase 2 | Stereotactic Ablative Radiotherapy With Nivolumab for Early-Stage Operable Non-Small Cell Lung Cancer | February 12, 2020 | November 15, 2023 |
| NCT01991418 | Completed | Early Warning Study of Serum Thioredoixn Reductase Activity in Excised Non-small Cell Lung Cancers (EWSOTRILC) | May 2013 | February 2016 | |
| NCT04342377 | Completed | Phase 3 | The Canada Lymph Node Score Project: A Crossover Trial | November 30, 2020 | June 30, 2022 |
| NCT05451173 | Not yet recruiting | Phase 1/Phase 2 | Combining ICI With SBRT or HypoFrx-RT for ES NSCLC | October 9, 2023 | December 31, 2025 |
| NCT06341387 | Recruiting | Volatolomic and Proteomic Profile for Early Diagnosis of Lung Cancer | May 5, 2023 | July 31, 2024 | |
| NCT02622581 | Recruiting | Clinical Research Platform Into Molecular Testing, Treatment and Outcome of (Non-)Small Cell Lung Carcinoma Patients | December 2015 | December 2027 | |
| NCT04585477 | Recruiting | Phase 2 | Adjuvant ctDNA-Adapted Personalized Treatment in Early Stage NSCLC (ADAPT-E) | April 8, 2021 | April 2026 |
| NCT04716946 | Recruiting | Phase 2 | Treating Early-stage Non-Small Cell Lung Cancer With Durvalumab and Radiation Therapy | January 27, 2021 | February 2025 |
| NCT04944173 | Recruiting | Phase 2 | SCION: SABR and Checkpoint Inhibition Of NSCLC | August 11, 2023 | June 2027 |
| NCT05097417 | Recruiting | N/A | Traditional Chinese Medicine Combined With Thermal and Cold Ablation for Early-stage Lung Cancer | November 1, 2021 | November 1, 2024 |
| NCT05453721 | Recruiting | N/A | Effect and Long-Term Outcomes of Indocyanine Green Fluorescence Imaging Method Versus Modified Inflation-Deflation Method in Identification of Intersegmental Plane（IMPLANE-0529） | August 4, 2022 | December 31, 2027 |
| NCT03172156 | Unknown status | ctDNA Dynamic Monitoring and Its Role of Prognosis in Stage I NSCLS by NGS | July 1, 2017 | December 31, 2019 | |
| NCT02011997 | Unknown status | Phase 3 | Comparison of cVATS Segmentectomy Versus Lobectomy for Lung Adenocarcinoma in Situ and With Microinvasion | December 2013 | December 2021 |
| NCT01795521 | Unknown status | Phase 2 | LungTech: Stereotactic Body Radiotherapy (SBRT) of Inoperable Centrally Located NSCLC | August 2015 | July 2021 |
| NCT03431415 | Withdrawn | N/A | Surgery Versus Stereotactic Body Radiation Therapy for Stage up to IA2 (T1a or T1b) Non-small Cell Lung Cancer | January 28, 2018 | February 2025 |
| NCT03029871 | Withdrawn | Phase 1 | Oncolytic Adenovirus-Mediated Gene Therapy for Lung Cancer | January 13, 2017 | December 31, 2022 |